Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 4, 2009, Pages 628-632

  Lippi, Giuseppe ^a   Targher, Giovanni ^a   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Zoppini, Giacomo ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORRELATION ANALYSIS; ERYTHROCYTE PARAMETERS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; OUTPATIENT; PREDICTION; RED BLOOD CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 64849108015     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24-38.
2. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: part I. Circulation. 2003;108:1917-1923.
3. Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem. 2008;54:335- 342.
4. Ledue TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem. 2003;49:1258-1271.
5. Tefferi A, Hanson CA, Inwards DJ. How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc. 2005;80:923-936.
6. Evans TC, Jehle D.The red blood cell distribution width. J Emerg Med. 1991; 9(suppl 1):71-74.
7. Felker GM, Allen LA, Pocock SJ, et al. CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50:40-47.
8. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M, for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163-168.
9. de Jonge N, Sewkaransing I, Slinger J, Rijsdijk JJ. Erythrocyte sedimentation rate by the test-1 analyzer. Clin Chem. 2000;46:881-882.
10. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107:1747-1750.
11. Scirica BM, Morrow DA, Cannon CP, et al. Thrombolysis in Myocardial Infarction (TIMI) Study Group. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clin Chem. 2007;53:1800-1807.
12. Libby P, Ridker PM. Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol. 2006;48:A33- A46.
13. Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol. 2006;26:261-268.
14. α, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003;14:1776-1784.
15. Selleri C, Maciejewski JP, Sato T, Young NS. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood. 1996;87:4149-4157.
16. Means RTJr, Krantz SB. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires β interferon. J Clin Invest. 1993;91:416-419.